SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-24-073710
Filing Date
2024-06-14
Accepted
2024-06-14 16:24:49
Documents
2
Period of Report
2024-06-14

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 5464
2 EX-24.1 crbp-ex24_1.htm EX-24.1 9443
  Complete submission text file 0000950170-24-073710.txt   16445
Mailing Address C/O CORBUS PHARMACEUTICALS HOLDINGS, INC 100 RIVER RIDGE DRIVE NORWOOD MA 02062
Business Address
HOLMER ALAN F (Reporting) CIK: 0001329585 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37348 | Film No.: 241045207

Mailing Address 500 RIVER RIDGE DRIVE NORWOOD MA 02062
Business Address 500 RIVER RIDGE DRIVE NORWOOD MA 02062 617-963-0103
Corbus Pharmaceuticals Holdings, Inc. (Issuer) CIK: 0001595097 (see all company filings)

IRS No.: 464348039 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)